Effect of testosterone on androgen deficiency
Not Applicable
- Conditions
- Androgen deficiency syndrome.Testicular hypogonadism NOS
- Registration Number
- IRCT201104236258N1
- Lead Sponsor
- Department of Research & Technology, Ahwaz JundiShapur University of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 24
Inclusion Criteria
inclusion criteria:Symptoms of androgen deficiency;Below normal rang of testosterone;age over 40 years
exclusion criteria:
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Erectile dysfunction, Sex Frequency. Timepoint: Baseline , 2 months after the first injection. Method of measurement: International Index of Erectile Function Questionnaire.;Fasting Blood Sugar -2hour post prandial- HemoglobinA1c. Timepoint: Baseline , 2 months after the first injection. Method of measurement: FBS(mg/dl), 2hPP(mg/dl), HbA1C(%).;Cholesterol, Triglyceride , High Density Lipoprotein, Low Density Lipoprotein. Timepoint: Baseline , 2 months after the first injection. Method of measurement: mg/dl.;Blood pressure. Timepoint: Baseline , 2 months after the first injection. Method of measurement: mmhg.
- Secondary Outcome Measures
Name Time Method ower urinary tract symptom. Timepoint: Baseline , 2 months after the first injection. Method of measurement: International Prostate Symptom Score.;Depression, Sleep disorders, Fatigue. Timepoint: Baseline , 2 months after the first injection. Method of measurement: BECK QUESTIONNAIR.